VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 2 filers reported holding VIRIDIAN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,329,807 | -12.9% | 209,505 | 0.0% | 1.15% | -45.6% |
Q4 2022 | $6,119,641 | +42.4% | 209,505 | 0.0% | 2.11% | +36.4% |
Q3 2022 | $4,297,000 | +77.3% | 209,505 | 0.0% | 1.55% | +102.4% |
Q2 2022 | $2,424,000 | -37.4% | 209,505 | 0.0% | 0.76% | -8.3% |
Q1 2022 | $3,874,000 | -6.5% | 209,505 | 0.0% | 0.83% | +44.8% |
Q4 2021 | $4,142,000 | +20.2% | 209,505 | 0.0% | 0.58% | +41.2% |
Q3 2021 | $3,446,000 | -10.1% | 209,505 | 0.0% | 0.41% | +2.5% |
Q2 2021 | $3,832,000 | +9.5% | 209,505 | 0.0% | 0.40% | -38.4% |
Q1 2021 | $3,501,000 | +1.6% | 209,505 | 0.0% | 0.65% | -16.4% |
Q4 2020 | $3,446,000 | – | 209,505 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 2,699,865 | $78,863,057 | 13.28% |
COMMODORE CAPITAL LP | 2,020,166 | $59,009 | 8.89% |
ACUTA CAPITAL PARTNERS, LLC | 396,500 | $11,581,765 | 7.13% |
Fairmount Funds Management LLC | 1,369,623 | $40,006,688 | 6.35% |
Paradigm Biocapital Advisors LP | 1,751,167 | $51,151,588 | 6.00% |
Vivo Capital, LLC | 1,678,207 | $49,020 | 5.64% |
TCG Crossover Management, LLC | 983,610 | $28,731,248 | 5.07% |
Kynam Capital Management, LP | 1,034,697 | $30,223,499 | 4.64% |
Octagon Capital Advisors LP | 824,200 | $24,074,882 | 3.75% |
Logos Global Management LP | 1,000,000 | $29,210,000 | 3.42% |